Tagged: targeted chemotherapy

Update from the Dean - March 2017

Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication management; Medicare Part D as a learning model for pharmacy education—impact 10 years out; New genetic insights into diabetes drug response; Annotating the ‘dark genome’; Epigenetics of ethnicity; New endowed professorships made possible by private support; New Center for Cellular Construction; Major funding for UCSF-Stanford CERSI; 2017 Mary Anne Koda-Kimble Seed Award for Innovation; Welcoming the class of 2020; Three generations at the School of Pharmacy; Developing a curriculum for 2018 and beyond; AFPE honors Frank Szoka as Mentor of the Year; 2016 Chancellor Diversity Awards honor Marcus Ferrone and Peace Chukudi; Eddie Way celebrates 100 years; CPhA Hall of Fame honors Brian Komoto, Phillip Oppenheimer, Wilma Wong; $500M gift to campus from Helen Diller Foundation; UC statement on federal executive order restricting travel and entry.

Renslo Lab develops new type of targeted chemotherapy that proves effective in mice

Research in the lab of UCSF School of Pharmacy faculty member Adam Renslo, PhD, has developed a new way of selectively targeting cancer cells with drugs. In experiments with mice, the new approach allowed for the delivery of fifty times higher doses of chemotherapy to tumors while avoiding toxic effects on healthy cells.